Chemoinformaics analysis of Butyric acid 1-hexenyl ester
| Molecular Weight | 170.252 | nRot | 6 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 2 |
| Exact Molecular Weight | 170.131 | nRing | 0 |
| Solubility: LogS | -2.998 | nHRing | 0 |
| Solubility: LogP | 3.131 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.3063 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.348 |
| Synth | 2.585 |
| Natural Product Likeliness | 1.948 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.104 |
| Pgp-sub | 0.011 |
| HIA | 0.003 |
| CACO-2 | -4.359 |
| MDCK | 0.0000326 |
| BBB | 0.989 |
| PPB | 0.772672 |
| VDSS | 0.404 |
| FU | 0.320163 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.696 |
| CYP2c19-inh | 0.679 |
| CYP2c19-sub | 0.631 |
| CYP2c9-inh | 0.443 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.22 |
| CYP2d6-sub | 0.448 |
| CYP3a4-inh | 0.192 |
| CYP3a4-sub | 0.215 |
| CL | 5.883 |
| T12 | 0.856 |
| hERG | 0.011 |
| Ames | 0.015 |
| ROA | 0.083 |
| SkinSen | 0.954 |
| Carcinogencity | 0.74 |
| EI | 0.983 |
| Respiratory | 0.568 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.955674 |